Classes: Monoclonal Antibodies, Anti-amyloid Beta
What is Aducanumab?
Aducanumab is under study as a possible treatment of early Alzheimer’s disease and currently pending FDA approval.
Uses of Aducanumab
- possible treatment of early Alzheimer’s disease.
Consult your doctor immediately if any side effects occur, worsen, persist or any serious side effects occur.
Consult your Physician.